Please login to the form below

Not currently logged in
Email:
Password:

CNS

This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

We are one of the first companies to focus on targeting IL-36 in dermatology,” said the privatey-held German company’s head of CNS and immunology R&D, Jan Poth.

Latest news

More from news
Approximately 4 fully matching, plus 163 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics